The pharmaceutical sector plays an important role in healthcare, meaning development goals must be established.

Deputy Prime Minister Trần Hồng Hà made the statement on Wednesday afternoon after hearing a report on the draft National Strategy for the development of Việt Nam’s pharmaceutical sector by 2030.

Hà said the draft strategy not only sets out the goals of the Government but also of the whole political system to improve the sector’s capability and the quality of healthcare.

Thus, the drafting agency needs to consider suitable goals to develop the sector and meet public demand, he said.

“The goals must be finished,” he said.

“And there has to be a clear direction and roadmap to carry them out,” he said.

It is necessary to clarify the ability to self-produce medicinal materials, the ranking of the Vietnamese pharmaceutical sector in research, production and product quality compared to other countries; as well as strike a balance between the development of a modern pharmaceutical sector and traditional medicine in order to promote the inherent potential and strengths, he said.

The capability of the domestic pharmaceutical sector must be defined when participating in the global pharmaceutical production and consumption chain as well as the ability to attract investors, owners of medicinal materials and technology transfer, he said.

More attention should be paid to the field of clinical pharmacy, assessing the effectiveness of drug use in health facilities, towards providing suitable and affordable drugs for patients, he said.

Managerial agencies, domestic and foreign pharmaceutical enterprises need to jointly share technology, harmonise interests in the production, supply and distribution of good quality drugs and reasonable prices, he said.

Specifically, by 2025, the strategy must identify priorities in investment in people, facilities, mechanisms and policies to develop the sector, he said.

The goals of the strategy must be feasible, competitive, effective and take advantage of the potential and strengths of the country, raising the rank of the pharmaceutical sector, he said.

Lê Quang Cường, former deputy minister of health said the demand for essential and common therapeutic drugs has been guaranteed so far, therefore, the pharmaceutical sector needs to focus on researching, testing and producing specialised and rare drugs.

Trịnh Văn Lẩu, former director of the National Institute of Drug Quality Control, suggested that there should be an institutional breakthrough to create favourable conditions and encourage enterprises to research and develop, receive and transfer technology for the production of modern drugs.

Supply of drugs
In a report revealed by the health ministry on Wednesday, the pharmaceutical sector has ensured the supply of drugs at reasonable prices, meeting the requirements of medical examination, treatment and prevention since 2011.

Drug production has been expanded with 228 factories meeting World Health Organisation – Good Manufacturing Practices (WHO-GMP) standards, including 18 production lines that have met European – Good Manufacturing Practices (EU-GMP) standards.

The total domestic pharmaceutical market value last year was estimated at US$6.2 billion.

The rate of unqualified drugs remained below two per cent. Domestically-produced versions meet 11 out of 12 vaccines in the country’s expanded immunisation programme.

Drug distribution and supply management activities are increasingly standardised, increasing people’s access to drugs.

However, the report also pointed out several shortcomings such as many domestic drug factories only invest in production lines focusing on common drugs instead of generic, specialised and brand-name drugs.

More than 90 per cent of raw materials for domestic drug production are still imported. The potential and strengths of traditional medicine have not been promoted, and there is a lack of human resources in the field of clinical pharmacy, quality management, research and development of new drugs.

Source: Vietnamnet


Stellapharm is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, antiviral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An City, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: | W:

You May like

28 Dec 2023


LONDON, April 26, 2023 (Reuters) – Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere. The biggest overhaul of existing medical laws in two decades is aimed at ensuring all Europeans

26 Dec 2023


The “Healthcare Innovation Forum”, a platform that brings together local and international experts to discuss and share experiences on innovative solutions in building a sustainable healthcare system worldwide and to drive the adoption of innovative approaches and technologies to transform healthcare in Vietnam. Diseases never stop developing, nor does innovation to deal with these obstacles.

09 Dec 2023


Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming

04 Dec 2023


On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;

22 Dec 2023


Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health Organisation, according to the National Strategy for Pharmaceutical Industry Development by 2023, with a vision toward 2045. Vietnam is striving to develop the pharmaceutical industry to level 4, the highest as classified by the World Health